Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RenovoRx, Inc. - Common Stock (NQ:RNXT)

2.090 +0.160 (+8.29%)
Streaming Delayed Price Updated: 3:40 PM EDT, Sep 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,127,383
Open 1.910
Bid (Size) 2.090 (300)
Ask (Size) 2.100 (300)
Prev. Close 1.930
Today's Range 1.830 - 2.200
52wk Range 0.7006 - 1.970
Shares Outstanding 36,649,916
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers ↗
RenovoRx (NASDAQ:RNXT) executives and physician speakers discussed the treatment landscape for locally advanced pancreatic cancer, the company’s Trans-Arterial Micro-Perfusion, or TAMP, platform, and... 
Via MarketBeat
News headline image
RenovoRx Q2 Earnings Call Highlights ↗
RenovoRx (NASDAQ:RNXT) reported record second-quarter revenue as it expanded its commercial cancer-center network and advanced its clinical program for locally advanced pancreatic cancer. For the... 
Via MarketBeat
Topics Earnings

Performance

YTD
+150.2%
+150.2%
1 Month
+97.2%
+97.2%
3 Month
+127.0%
+127.0%
6 Month
+137.0%
+137.0%
1 Year
+93.5%
+93.5%

More News

Read More
News headline image
RenovoRx (RNXT) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
iAccess Alpha Virtual Best Ideas Summer Investment Conference Begins Today
From iAccess Alpha
Via ACCESS Newswire
News headline image
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026
From iAccess Alpha
Via ACCESS Newswire
News headline image
RenovoRx (RNXT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
From Equity Insider
Via GlobeNewswire
News headline image
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop ↗
Via Chartmill
News headline image
RenovoRx (RNXT) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
Via ACCESS Newswire
News headline image
iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025
Via ACCESS Newswire
News headline image
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
Via Chartmill
News headline image
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 27th Annual Global Investment Conference in New York City, September 8-10, 2025
From RenovoRx, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Gapping stocks in Friday's session ↗
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
RenovoRx Revenue Jumps 28 Percent in Q2 ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is RenovoRx, Inc. - Common Stock publicly traded?
Yes, RenovoRx, Inc. - Common Stock is publicly traded.
What exchange does RenovoRx, Inc. - Common Stock trade on?
RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RenovoRx, Inc. - Common Stock?
The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market
What is the current price of RenovoRx, Inc. - Common Stock?
The current price of RenovoRx, Inc. - Common Stock is 2.090
When was RenovoRx, Inc. - Common Stock last traded?
The last trade of RenovoRx, Inc. - Common Stock was at 09/01/26 03:40 PM ET
What is the market capitalization of RenovoRx, Inc. - Common Stock?
The market capitalization of RenovoRx, Inc. - Common Stock is 76.60M
How many shares of RenovoRx, Inc. - Common Stock are outstanding?
RenovoRx, Inc. - Common Stock has 77M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS